« Previous
Next »
Titles
- 340B Drug Discount Program: oversight of the Intersection with the Medicaid Drug Rebate Program needs improvement : report to Congressional requesters1
- Air travel and communicable diseases: status of research efforts and action still needed to develop federal preparedness plan : testimony before the Subcommittee on Space and Aeronautics, Committee on Science, Space, and Technology, House of Representatives1
- Antibiotic resistance: additional federal actions needed to better determine magnitude and reduce impact1
- Arkansas Medicaid Fraud Control Unit: 2019 onsite inspection1
- Billions in estimated Medicare Advantage payments from diagnoses reported only on health risk assessments raise concerns1
- Black Lung Benefits Program: oversight is needed to address trust fund solvency strained by bankruptcies : testimony before the Committee on Education and Labor, Subcommittee on Workforce Protections, House of Representatives1
- CMS should pursue strategies to increase the number of at-risk beneficiaries acquiring naloxone through Medicaid1
- CMS’s encounter data lack essential information that Medicare Advantage organizations have the ability to collect1
- COVID-19: brief update on initial federal response to the pandemic : report to Congress1
- COVID-19: opportunities to improve federal response and recovery efforts : report to the Congress1
- COVID-19: urgent actions needed to better ensure an effective federal response : report to Congressional committees1
- Clinical labs: studies suggest biopsy specimen misidentification and contamination errors are infrequent : report to the Ranking Member, Committee on Finance, U.S. Senate1
- Communication and management challenges impeded HHS's response to the zero-tolerance policy1
- Comparative effectiveness research: Patient-Centered Outcomes Research Institute and HHS continue activities and plan new efforts : report to Congressional committees1
- Defense health care: additional information and monitoring needed to better position DOD for restructuring medical treatment facilities : report to Congressional committees1
- Defense health care: plans needed to ensure implementation of required elements for TRICARE’s managed care support contracts : report to Congressional committees1
- Despite savings on many lab tests in 2019, total Medicare spending increased slightly because of increased utilization for certain high-priced tests1
- Drug misuse: sustained national efforts are necessary for prevention, response, and recovery : report to the Congress1
- Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate1
- Enforcement priorities for electronic nicotine delivery systems (ENDS) and other deemed products on the market without premarket authorization1